| 标题 |
Latest Results From an Ongoing First-in-Human Phase 1a/B Study of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients With Relapsed/Refractory CLL and Other B-Cell Malignancies |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma, Myeloma & Leukemia 作者:K. Linton; Graham P Collins; Francesco Forconi; Nirav N. Shah; K. Dixit; et al 出版日期:2024-09-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)